MedPath

Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients

Phase 4
Conditions
Opiate Withdrawal Syndrome
Chronic Pain
Interventions
Other: Sham acupuncture
Other: NADA acupuncture
Registration Number
NCT03397212
Lead Sponsor
Rigshospitalet, Denmark
Brief Summary

This project aims at examining the following hypotheses:

* Treatment with NADA and clonidine reduces intensity of withdrawal symptoms to a greater extent than treatment with clonidine.

* Opioid withdrawal improves pain, physical and mental functioning and reduces opioid consumption 3 months and 1 year after withdrawal.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Chronic pain patients treated with opioids over 3 months
  • The patient's doctor or nurse assesses that there is an indication to opioid withdrawal and / or the patient wishes to withdraw.
  • The patient is motivated for opioid withdrawal
  • The patient has experienced withdrawal symptoms
  • The patient must be able to understand, speak and write Danish
  • The patient must be able to transport himself to the pain center
Exclusion Criteria
  • Children under 18 years old
  • External ear infection
  • Treatment with benzodiazepines.
  • Active substance abuse and alcohol abuse.
  • Contraindications for treatment with clonidine:
  • Allergy
  • Bradyarrhythmias caused by diseased sinus cube or AV block of 2nd or 3rd grade.
  • lactose intolerance
  • Heart failure
  • High medullary damage
  • Cardiac conduction disturbances
  • Pregnancy and breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Sham acupuncture and ClonidineSham acupunctureSham ear acupuncture and treatment with tbl Clonidine
NADA and ClonidineNADA acupunctureNADA acupuncture and treatment with tbl Clonidine
Primary Outcome Measures
NameTimeMethod
Change in intensity of withdrawal symptoms3 months and 1 year

Change in intensity of withdrawal symptoms assessed with Danish withdrawal symptom questionnaire

Secondary Outcome Measures
NameTimeMethod
Change in quality of life assessed with SF363 months and 1 year

Change in quality of life assessed with SF36

Trial Locations

Locations (1)

Rigshospitalet

🇩🇰

Copenhagen, Denmark

© Copyright 2025. All Rights Reserved by MedPath